{"prompt": "['CONFIDENTIAL', 'Protocol ANB019-002 - Amendment 5', 'Definition of SAE', 'An SAE is defined as any untoward medical occurrence that, at any dose:', 'a) Results in death', 'b) Is life-threatening', 'The term \"life-threatening\\' in the definition of \"serious\" refers to an event in which the subject was at risk', 'of death at the time of the event. It does not refer to an event, which hypothetically might have caused', 'death, if it were more severe.', 'c) Requires inpatient hospitalization or prolongation of existing hospitalization', 'In general, hospitalization signifies that the subject has been detained (usually involving at least an', 'overnight stay) at the hospital or emergency ward for observation and/or treatment that would not have', \"been appropriate in the physician's office or outpatient setting. Complications that occur during\", 'hospitalization are AEs. If a complication prolongs hospitalization or fulfils any other serious criteria, the', 'event is serious. When in doubt as to whether \"hospitalization\" occurred or was necessary, the AE should', 'be considered serious.', 'Hospitalization for elective treatment of a pre-existing condition that did not worsen from baseline is not', 'considered an AE.', 'd) Results in persistent disability/incapacity', \"The term disability means a substantial disruption of a person's ability to conduct normal life\", 'functions.', 'This definition is not intended to include experiences of relatively minor medical significance such as', 'uncomplicated headache, nausea, vomiting, diarrhea, influenza, and accidental trauma (eg, sprained', 'ankle) which may interfere with or prevent everyday life functions but do not constitute a substantial', 'disruption.', 'e) Is a congenital anomaly/birth defect', 'f)', 'Other situations:', '.', 'Medical or scientific judgment should be exercised in deciding whether SAE reporting is appropriate', 'in other situations such as important medical events that may not be immediately life-threatening or', 'result in death or hospitalization but may jeopardize the subject or may require medical or surgical', 'intervention to prevent 1 of the other outcomes listed in the above definition. These events should', 'usually be considered serious.', 'Examples of such events include invasive or malignant cancers, intensive treatment in an emergency', 'room or at home for allergic bronchospasm, blood dyscrasias, or convulsions that do not result in', 'hospitalization, or development of drug dependency or drug abuse.', '29 October 2019', '70']['CONFIDENTIAL', 'Protocol ANB019-002 - Amendment 5', 'Recording and Follow-up of AE and/or SAE', 'AE and SAE Recording', 'When an AE/SAE occurs, it is the responsibility of the Investigator to review all documentation (eg,', 'hospital progress notes, laboratory reports, and diagnostics reports) related to the event.', 'The Investigator will then record all relevant AE/SAE information in the CRF. Each event must be', 'recorded separately.', \"It is not acceptable for the Investigator to send photocopies of the subject's medical records to\", 'Safety in lieu of completion of the /AE/SAE CRF page.', 'There may be instances when copies of medical records for certain cases are requested by', 'Safety. In this case, all subject identifiers, with the exception of the subject number, will be', 'redacted on the copies of the medical records before submission to', 'Safety.', 'The Investigator will attempt to establish a diagnosis of the event based on signs, symptoms, and/or', 'other clinical information. Whenever possible, the diagnosis (not the individual signs/symptoms) will', 'be documented as the AE/SAE.', 'Assessment of Intensity', 'The Investigator will make an assessment of intensity for each AE and SAE reported during the study and', 'assign it to 1 of the following categories:', 'Mild: An event that is easily tolerated by the subject, causing minimal discomfort and not interfering', 'with everyday activities.', 'Moderate: An event that causes sufficient discomfort and interferes with normal everyday activities.', 'Severe: An event that prevents normal everyday activities. An AE that is assessed as severe should not', 'be confused with a SAE. Severe is a category utilized for rating the intensity of an event; and both AEs', 'and SAEs can be assessed as severe.', \"An event is defined as 'serious' when it meets at least 1 of the predefined outcomes as described in the\", 'definition of an SAE, NOT when it is rated as severe.', 'Assessment of Causality', 'The Investigator is obligated to assess the relationship between study treatment and each occurrence of', 'each AE/SAE. The AE must be characterized as unrelated, possibly related, and related.', '\"Unrelated\" clinical event with an incompatible time relationship to study drug', 'administration, and that could be explained by an underlying condition or other drugs or', 'chemicals or is incontrovertibly not related to the IP', '\"Possibly related\" Clinical event with a reasonable time relationship to study drug', 'administration, and that is unlikely to be attributed to concurrent condition or other drugs or', 'chemicals', '\"Related\" Clinical event with plausible time relationship to study drug administration and that', 'cannot be explained by concurrent condition or other drugs or chemicals', 'The Investigator will use clinical judgment to determine the relationship.', 'Alternative causes, such as underlying disease(s), concomitant therapy, and other risk factors, as well', 'as the temporal relationship of the event to study treatment administration will be considered and', 'investigated.', 'The Investigator will also consult the IB and/or Product Information, for marketed products, in his/her', 'assessment.', 'For each AE/SAE, the Investigator must document in the medical notes that he/she has reviewed the', 'AE/SAE and has provided an assessment of causality.', '29 October 2019', '71']\n\n###\n\n", "completion": "END"}